TECHNOLOGY SUMMARY

Current and future threats to global biosecurity are predominantly due to infectious pathogens. Our platform technology of molecules bind to DNA at multiple sites to kill pathogens of many different infectious disease types including bacteria, fungi, viruses and parasites, with a unique mechanism of action to delay resistance development.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech, Pharma, Health

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

Vetted Programs/Awards: £20k INSPIRE 100 award out of the University of Strathclyde for the most 'investable' spin out company.

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

Website: https://www.rostratx.com

Showcase Booth #: M59

MARKET KEYWORDS

Market Keywords: Infection, fungal, resistance